The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

Published:1992-03 Issue:3 Part 2 Volume:147 Page:956-961
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Miller Jeffrey I.¹,Ahmann Frederick R.¹,Drach George W.¹,Emerson Scott S.¹,Bottaccini Manfred R.¹

Affiliation:

1. From the Departments of Urology and Hematology/Oncology, Arizona Cancer Center, University of Arizona Health Sciences Center and Tucson Veterans Administration Medical Center, Tucson, Arizona

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference41 articles.

1. Carcinoma of the prostate-hormonal therapy;Grayhack;Cancer,1987

2. PSA in the screening, staging and follow-up of early-stage prostate cancer. A review of recent developments;Brawer;World J. Urol.,1989

3. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients;Stamey;J. Urol.,1989

4. Clinical use of prostate specific antigen in patients with prostate cancer;Hudson;J. Urol.,1989

5. Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer;Cooper;Cancer,1990

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flare on [18F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients;European Journal of Nuclear Medicine and Molecular Imaging;2022-09-26

2. Nomogram Incorporating Contrast-Enhanced Ultrasonography Predicting Time to the Development of Castration-Resistant Prostate Cancer;Clinical Medicine Insights: Oncology;2021-01

3. Factores relacionados con la resistencia a la castración precoz en el cáncer de próstata metastásico. Resultados del Registro nacional de cáncer de próstata en España;Actas Urológicas Españolas;2019-12

5. Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis;F1000Research;2018-02-28